You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HSV

Showing 1 - 25 of 483
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Herpes Simplex Trial in Tokyo (HSVTI Formulation 1, HSVTI Formulation 2, Placebo)

Not yet recruiting
  • Herpes Simplex
  • HSVTI Formulation 1
  • +2 more
  • Tokyo, Japan
    GSK Investigational Site
Aug 4, 2023

Obese Patients Receiving Acyclovir for HSV Encephalitis

Enrolling by invitation
  • HSV Encephalitis
  • To assess the clinical impact of dosing acyclovir based on IBW or adjBW for HSV encephalitis to definitively guide safe and effective therapy.
  • Dallas, Texas
    Methodist Charlton Medical Center
Sep 12, 2022

Recurrent High Grade Glioma Trial (MVR-C5252)

Not yet recruiting
  • Recurrent High Grade Glioma
  • MVR-C5252
  • (no location specified)
Nov 6, 2023

Dystrophic Epidermolysis Bullosa Trial in Stanford (Topical beremagene geperpavec)

Completed
Has Results
  • Dystrophic Epidermolysis Bullosa
  • Topical beremagene geperpavec
  • Placebo gel
  • Stanford, California
    Stanford University
Jan 30, 2023

Herpes Simplex 2, Meningitis, Viral Trial (Acyclovir 50 MG/ML, Placebo)

Not yet recruiting
  • Herpes Simplex 2
  • Meningitis, Viral
  • Acyclovir 50 MG/ML
  • Placebo
  • (no location specified)
Jul 11, 2022

NOWDx Test for the Diagnosis of Herpes Simplex Virus Type 2

Suspended
  • HSV-2 Infection
  • Herpes Simplex Virus Infection
  • Diagnostic Test: NOWDx HSV-2 Test
  • Tempe, Arizona
  • +2 more
Sep 29, 2022

Recurrent Genital Herpes Trial (UB-621)

Not yet recruiting
  • Recurrent Genital Herpes
  • UB-621
  • (no location specified)
May 16, 2022

Tumors, High Grade Glioma, Glioblastoma Multiforme Trial in Birmingham (Biological G207)

Not yet recruiting
  • Neoplasms
  • +7 more
  • Biological G207
  • Birmingham, Alabama
    Children's of Alabama
Jun 1, 2022

HSV Trial (Pritelivir)

Available
  • HSV
  • (no location specified)
Apr 25, 2023

Herpes Simplex-virus Type 1 (HSV-1) Reactivation

Recruiting
  • Tracheobronchitis
  • Herpes Simplex Infection
  • Patients with herpes-simplex infection requiring bronchoscopy
  • Münster, Germany
    University Hospital Münster
Apr 11, 2022

Virus, HSV-1, Herpes Simplex 1 Trial in Pocatello, Saint George (Purell Hand Sanitizer, Medical Grade Mineral Oil)

Recruiting
  • Virus
  • +3 more
  • Purell Hand Sanitizer
  • Medical Grade Mineral Oil
  • Pocatello, Idaho
  • +2 more
Nov 13, 2023

Genital Herpes Trial in United States (mRNA-1608, BEXSERO)

Recruiting
  • Genital Herpes
  • mRNA-1608
  • BEXSERO
  • Birmingham, Alabama
  • +24 more
Sep 11, 2023

Pneumonia, Viral, Ventilator Associated Pneumonia, Community-acquired Pneumonia Trial (Acyclovir)

Not yet recruiting
  • Pneumonia, Viral
  • +4 more
  • (no location specified)
Nov 16, 2023

Primary Hepatocellular Carcinoma Trial (Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)), camrelizumab for

Not yet recruiting
  • Primary Hepatocellular Carcinoma
  • Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell))
  • camrelizumab for Injection
  • (no location specified)
Nov 13, 2023

HSV Infection Trial (walnut extract)

Completed
  • HSV Infection
  • walnut extract
  • (no location specified)
Oct 16, 2023

HSV, Herpes Labialis Trial in Saint Paul (Squaric Acid Dibutyl Ester)

Completed
Has Results
  • HSV
  • Herpes Labialis
  • Squaric Acid Dibutyl Ester
  • Saint Paul, Minnesota
    Prism Clinical Research, LLC
Oct 5, 2021

Genital Herpes Simplex Type 2 Trial (BNT163, Placebo)

Not yet recruiting
  • Genital Herpes Simplex Type 2
  • BNT163
  • Placebo
  • (no location specified)
Jun 21, 2022

Metastatic Gastric Cancer Trial in Beijing (Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)), Nivolumab

Recruiting
  • Metastatic Gastric Cancer
  • Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell))
  • Nivolumab Injection
  • Beijing, Beijing, China
    Peking University Cancer Hospital
Aug 23, 2023

Supratentorial Tumors, Malignant, Malignant Glioma, Glioblastoma Trial in Birmingham, Columbus (G207)

Active, not recruiting
  • Supratentorial Neoplasms, Malignant
  • +6 more
  • G207
  • Birmingham, Alabama
  • +1 more
Jun 1, 2022

Recurrent Glioblastoma Multiforme, Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma or Gliosarcoma Trial in

Active, not recruiting
  • Recurrent Glioblastoma Multiforme
  • +2 more
  • M032 (NSC 733972)
  • Birmingham, Alabama
    University of Alabama at Birmingham
Jan 26, 2022

Sarcoma Trial in Beijing (Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell))

Recruiting
  • Sarcoma
  • Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)
  • Beijing, China
    Peking University People's Hospital
Nov 6, 2023

Immune Defects in Patients Without Known Immunocompromise

Recruiting
  • EBV
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 11, 2023

    Herpes Simplex Trial in Lenexa, Rochester (Lower dose formulation of HSV vaccine (GSK4108771A), Low dose formulation of HSV

    Terminated
    • Herpes Simplex
    • Lower dose formulation of HSV vaccine (GSK4108771A)
    • +4 more
    • Lenexa, Kansas
    • +1 more
    Jun 24, 2021

    Colitis, Ulcerative Trial in Saint-Etienne (rectosigmoidoscopy, biopsies, blood sample)

    Recruiting
    • Colitis, Ulcerative
    • rectosigmoidoscopy
    • +2 more
    • Saint-Etienne, France
      CHU Saint-Etienne
    Nov 16, 2021

    Glioblastoma Multiforme of Brain, Anaplastic Astrocytoma of Brain, Gliosarcoma of Brain Trial in Birmingham (C134)

    Active, not recruiting
    • Glioblastoma Multiforme of Brain
    • +2 more
    • C134
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Sep 19, 2022